About Core Diagnostics
Core Diagnostics is a company based in Hayward (United States) founded in 2014 was acquired by Canopy Biosciences in December 2019. The company has 9 employees as of December 31, 2018. Core Diagnostics operates in a competitive market with competitors including Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.
- Headquarter Hayward, United States
- Employees 9 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Core Diagnostics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
9
as on Dec 31, 2018
-
Acquired by
Canopy Biosciences
(Dec 04, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Core Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Core Diagnostics
Detailed funding history for Core Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Core Diagnostics
Core Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Canopy Biosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cell line engineering services are offered via CRISPR-Cas9 technology.
|
Locked | Locked | Locked |
Investor details for Core Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Core Diagnostics
Investment portfolio details for Core Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Core Diagnostics
Detailed financials for Core Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Core Diagnostics Comparisons
Peer comparison for Core Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Core Diagnostics
Core Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
Detailed competitors of Core Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Core Diagnostics
Complete news archive for Core Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Core Diagnostics
Core Diagnostics was founded in 2014.
Core Diagnostics is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
As of Dec 31, 2018, the latest employee count at Core Diagnostics is 9.
Core Diagnostics was founded in 2014 and is based in Hayward, United States. Operations focus on the biotechnology and diagnostics sector, where histopathology services, immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), high-throughput gene expression analysis, nanoString nCounter-based studies, and mutational analysis are conducted. These offerings support biomarker research and translational applications for clients in the life sciences field.
Core Diagnostics's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.
Core Diagnostics has 1 investor. Key investors include Canopy Biosciences.